Dr. Nola Hylton’s path to becoming one of the pre-eminent scientists in the field of biomedical imaging stretches back to childhood when she carried a deep curiosity about the world and “why things are as they are.” In this Q&A, Dr. Hylton talks about choosing a career that would have an impact on others, her enduring excitement for her work, and mentoring women of color in science.
Katherine Van Loon, MD, and Jordyn Silverstein, MD, from UC San Francisco discuss the unique challenges pregnancy associated cancers (PAC) pose for women and their care teams, who must balance both safety of the mother and that of the fetus or embryo.
Eleven investigators and teams were awarded grants in support of cancer research projects in the spring 2022 cycle of the UCSF Resource Allocation Program (RAP). Read more about the recent awardees and their cancer research projects.
While children receiving chemotherapy routinely undergo hearing tests, adults don’t, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer.
Using new technologies to study thousands of genes simultaneously within immune cells, researchers at Gladstone Institutes, UC San Francisco (UCSF), and Stanford School of Medicine have created the most detailed map yet of how complex networks of genes function together.
Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology. In this interview, Komanduri discusses expanding access to precision medicine, his goals for translational research and why he’s landed his dream job.
Dr. Jenna Lester founded the Skin of Color Program at UC San Francisco, which includes a training clinic that specializes in treating dark skin. There are just a handful of such clinics across the country, and Lester’s is the only one in Northern California.
Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today's Visionaries in Cancer Immunotherapy Research
UCSF's Kole Roybal, PhD and Matt Spitzer, PhD were named among six U.S. scientists to be awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with the potential to transform cancer treatment.
A world-class team of researchers, co-led by UCSF’s Allan Balmain, and including Kim Rhoads and Luke Gilbert, has been selected to receive a $25M Cancer Grand Challenges award to investigate the very early stages of cancer development.
In a groundbreaking finding, a new study led by UC San Francisco found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women.
Announcing the Cancer Center See Us Portrait Project, a series of portraits and quotes by Black, Indigenous, People of Color (BIPOC) faculty and staff who are dedicated leaders in diversity, equity, and inclusion, and exhibit UCSF's PRIDE values.